Lack of mitochondrial toxicity in CEM cells treated with carbovir (Q41112334)

26 September 2017

Lack of mitochondrial toxicity in CEM cells treated with carbovir (English)

1 reference

26 September 2017

Parker WB

1

1 reference

26 September 2017

Shaddix SC

series ordinal

2

1 reference

26 September 2017

Vince R

series ordinal

3

1 reference

26 September 2017

Bennett LL Jr

series ordinal

4

1 reference

26 September 2017

1 May 1997

1 reference

26 September 2017

1 reference

26 September 2017

34

1 reference

26 September 2017

131-136

1 reference

26 September 2017

3

1 reference

Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Mitochondrial myopathy caused by long-term zidovudine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomer

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Carbovir: the (—) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Metabolism of the carbocyclic nucleoside analogue carbovir, an inhibitor of human immunodeficiency virus, in human lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Metabolism of carbovir, a potent inhibitor of human immunodeficiency virus type 1, and its effects on cellular metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Purification of all forms of HeLa cell mitochondrial DNA and assessment of damage to it caused by hydrogen peroxide treatment of mitochondria or cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

Pharmacokinetics and bioavailability of carbovir, a carbocyclic nucleoside active against human immunodeficiency virus, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2901033-4

7 January 2021

10.1016/S0166-3542(97)01033-4

Identifiers

DOI

1 reference

26 September 2017

1 reference